120 related articles for article (PubMed ID: 24913812)
1. Serum CA125 level predicts prognosis in patients with multiple brain metastases from non-small cell lung cancer before and after treatment of whole-brain radiotherapy.
Zeng YC; Wu R; Wang SL; Chi F; Xing R; Cai WS; Fan GL; Fan YC; Zhong WZ; Wu LN; Chen XD; Chen HH; Xiao YP
Med Oncol; 2014 Jul; 31(7):48. PubMed ID: 24913812
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of serum CA125 level in patients with advanced non-small cell lung cancer].
Hu Y; Zhong A; Yang X
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):30-1. PubMed ID: 11776591
[TBL] [Abstract][Full Text] [Related]
4. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
5. The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L
Radiat Oncol; 2016 Jul; 11():92. PubMed ID: 27411944
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
[TBL] [Abstract][Full Text] [Related]
9. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
[TBL] [Abstract][Full Text] [Related]
10. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
12. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of prognostic factors in NSCLC patients with brain metastases
diagnosed by constrast-enhanced MRI after whole brain radiotherapy].
Liu H; Wu Q; Gong X; He X; Wu H; Sheng Z; Zhou D
Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):719-22. PubMed ID: 21924038
[TBL] [Abstract][Full Text] [Related]
14. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
Cedrés S; Nuñez I; Longo M; Martinez P; Checa E; Torrejón D; Felip E
Clin Lung Cancer; 2011 May; 12(3):172-9. PubMed ID: 21663860
[TBL] [Abstract][Full Text] [Related]
16. Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy.
Anami S; Doi H; Nakamatsu K; Uehara T; Wada Y; Fukuda K; Inada M; Ishikawa K; Kanamori S; Nishimura Y
J Radiat Res; 2019 Mar; 60(2):257-263. PubMed ID: 30576550
[TBL] [Abstract][Full Text] [Related]
17. Treatment of brain metastases from primary lung cancer.
Ryan GF; Ball DL; Smith JG
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):273-8. PubMed ID: 7836080
[TBL] [Abstract][Full Text] [Related]
18. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
[TBL] [Abstract][Full Text] [Related]
19. Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer.
Chao A; Tang YH; Lai CH; Chang CJ; Chang SC; Wu TI; Hsueh S; Wang CJ; Chou HH; Chang TC
Gynecol Oncol; 2013 Jun; 129(3):500-4. PubMed ID: 23458702
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation.
Rodrigus P; de Brouwer P; Raaymakers E
Lung Cancer; 2001 May; 32(2):129-36. PubMed ID: 11325483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]